Filter News
Area of Research
- (-) Biology and Soft Matter (1)
- (-) Computational Biology (1)
- (-) Isotopes (5)
- Biological Systems (1)
- Biology and Environment (47)
- Clean Energy (56)
- Climate and Environmental Systems (1)
- Computational Engineering (1)
- Fusion and Fission (6)
- Fusion Energy (1)
- Materials (21)
- Materials for Computing (6)
- National Security (9)
- Neutron Science (13)
- Nuclear Science and Technology (8)
- Supercomputing (32)
News Topics
- (-) Biomedical (5)
- (-) Climate Change (2)
- Artificial Intelligence (1)
- Biology (1)
- Chemical Sciences (1)
- Computer Science (2)
- Coronavirus (1)
- Decarbonization (1)
- Environment (2)
- High-Performance Computing (1)
- Isotopes (21)
- Materials (3)
- Materials Science (2)
- National Security (1)
- Neutron Science (1)
- Nuclear Energy (3)
- Security (1)
- Space Exploration (3)
Media Contacts
Raina Setzer knows the work she does matters. That’s because she’s already seen it from the other side. Setzer, a radiochemical processing technician in Oak Ridge National Laboratory’s Isotope Processing and Manufacturing Division, joined the lab in June 2023.
Three scientists from the Department of Energy’s Oak Ridge National Laboratory have been elected fellows of the American Association for the Advancement of Science, or AAAS.
ORNL biogeochemist Elizabeth Herndon is working with colleagues to investigate a piece of the puzzle that has received little attention thus far: the role of manganese in the carbon cycle.
As a medical isotope, thorium-228 has a lot of potential — and Oak Ridge National Laboratory produces a lot.
An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.
A rare isotope in high demand for treating cancer is now more available to pharmaceutical companies developing and testing new drugs.
When Sandra Davern looks to the future, she sees individualized isotopes sent into the body with a specific target: cancer cells.